Related Experiment Video
Updated: May 13, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
CXCL5 stimulation of RANK ligand expression in Paget's disease of bone
Kumaran Sundaram1, D Sudhaker Rao, William L Ries
1Charles P Darby Children's Research Institute, Charleston, SC 29425, USA.
Abstract:
Paget's disease of bone (PDB) is a chronic focal skeletal disorder that affects 2-3% of the population over 55 years of age. PDB is marked by highly localized areas of bone turnover with increased osteoclast activity. Evidence suggests a functional role for measles virus nucleocapsid protein (MVNP) in the pathogenesis of PDB. In the present study, we identified elevated levels (≈ 180-fold) of CXCL5 mRNA expression in bone marrow cells from patients with PDB compared with that in normal subjects. In addition, CXCL5 levels are increased (five-fold) in serum samples from patients with PDB. Furthermore, MVNP transduction in human bone marrow monocytes significantly increased CXCL5 mRNA expression. Real-time PCR analysis showed that CXCL5 stimulation increased (6.8-fold) RANKL mRNA expression in normal human bone marrow-derived stromal (SAKA-T) cells. Moreover, CXCL5 increased (5.2-fold) CXCR1 receptor expression in these cells. We further showed that CXCL5 treatment elevated the expression levels of phospho-ERK1/2 and phospho-p38. CXCL5 also significantly increased phosphorylation of CREB (cAMP response element-binding) in bone marrow stromal/preosteoblast cells. Chromatin immuneprecipitation (ChIP) assay confirmed phospho-CREB binding to RANKL gene promoter region. Further, the suppression of p-CREB expression by the inhibitors of ERK1/2, p38 and PKA significantly decreased CXCL5 stimulation of hRANKL gene promoter activity. Thus, our results suggest that CREB is a downstream effector of CXCL5 signaling and that increased levels of CXCL5 contribute to enhanced levels of RANKL expression in PDB.
Insights
Elevated CXCL5 levels, potentially linked to measles virus nucleocapsid protein (MVNP), drive increased RANKL expression in Paget's disease of bone (PDB). This suggests CXCL5 signaling, mediated by CREB, is a key factor in PDB pathogenesis.
Area of Science:
- Bone Biology
- Immunology
- Virology
Background:
- Paget's disease of bone (PDB) is a common skeletal disorder over age 55, characterized by heightened bone turnover and osteoclast hyperactivity.
- The measles virus nucleocapsid protein (MVNP) is implicated in PDB pathogenesis.
- CXCL5 mRNA and protein levels are significantly elevated in PDB patients.
Purpose of the Study:
- To investigate the role of CXCL5 in Paget's disease of bone (PDB) pathogenesis.
- To elucidate the molecular mechanisms by which CXCL5 influences bone turnover in PDB.
Main Methods:
- Quantitative real-time PCR to measure mRNA expression (CXCL5, RANKL, CXCR1).
- Western blotting to assess protein phosphorylation (ERK1/2, p38, CREB).
- Chromatin immunoprecipitation (ChIP) assay to confirm transcription factor binding.
Main Results:
- CXCL5 mRNA and serum levels were substantially increased in PDB patients.
- MVNP transduction elevated CXCL5 expression in human bone marrow monocytes.
- CXCL5 stimulation upregulated RANKL and CXCR1 expression, activating ERK1/2, p38, and CREB signaling pathways.
- Phospho-CREB was confirmed to bind the RANKL gene promoter, mediating CXCL5-induced RANKL expression.
Conclusions:
- CXCL5 is significantly elevated in PDB and contributes to increased RANKL expression.
- CXCL5 signaling, through CREB activation, plays a crucial role in the enhanced bone turnover observed in PDB.
- These findings highlight CXCL5 as a potential therapeutic target for Paget's disease of bone.
Related Concept Videos
Osteoclasts in Bone Remodeling
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells